|
|
Please log in to edit this profile
|
| Elevator Pitch |
iPierian, formerly iZumi Bio, is the first company to apply cellular reprogramming and directed differentiation to cells that are derived from patients representing a broad spectrum of diseases. |
| Industry Focus |
BioPharma |
| Category |
Companies - Early Stage |
|
|
|
Amount: $500,000
Closed: June 24, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: June, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: June, 2009
|
|
|
|
| Be the first to recommend iPierian!
Log in |
Public information, member edits, and the DealHorizon.com team.
|
Office Location
Statistics
Search Site
Edit/Update
Followers
Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing
creators are also automatically added as followers.
|
